SCHEMBL2174072

SCHEMBL2174072

CC1CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16657572 1.00
SCHEMBL20547768 1.00
SCHEMBL12602390 0.97 CA1 (0.65)
SCHEMBL12602391 0.80 CA1 (0.48)
SCHEMBL13057193 0.80
SCHEMBL10811426 0.80 CA1 (0.54)
SCHEMBL22171228 0.80
SCHEMBL5918105 0.80 CA1 (0.48)
SCHEMBL11124096 0.80 CA1 (0.42)
SCHEMBL2343477 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4693488-A1 POSITIVE ELECTRODE MATERIAL, AND ELECTROCHEMICAL DEVICE AND ELECTRIC DEVICE COMPRISING SAME Ningde Amperex Technology Limited (CN) 2026-02-11 EP disclosed
US-20260031348-A1 POSITIVE ELECTRODE MATERIAL, AND ELECTROCHEMICAL APPARATUS AND ELECTRIC APPARATUS CONTAINING SUCH POSITIVE ELECTRODE MATERIAL NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2026-01-29 US disclosed
WO-2025137267-A1 MODULATORS OF TNF-ALPHA ACTIVITY FORWARD THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed
WO-2025132730-A1 POLYISOCYANATE MIXTURE COVESTRO DEUTSCHLAND AG (DE) 2025-06-26 WO disclosed
EP-4574863-A1 POLYISOCYANATE MIXTURE Covestro Deutschland AG (DE) 2025-06-25 EP disclosed
US-20250174725-A1 SECONDARY BATTERY AND ELECTRONIC APPARATUS DONGGUAN AMPEREX TECHNOLOGY LIMITED (CN) 2025-05-29 US disclosed
EP-4560766-A2 SECONDARY BATTERY AND ELECTRONIC APPARATUS Dongguan Amperex Technology Limited (CN) 2025-05-28 EP disclosed
US-20250127795-A1 Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity UCB Biopharma SRL (BE) 2025-04-24 US disclosed
US-20240300946-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION 2024-09-12 US disclosed
CN-117430588-A Pyridazinone heterocyclic compound Myosin II inhibitor and application thereof 西藏海思科制药有限公司 2024-01-23 CN disclosed
EP-0319864-A1 Binder combinations, process for their preparation and their use BAYER AG (DE) 1989-06-14 EP disclosed
US-4804782-A ARTIFICIAL SWEETENER PFIZER, INC. (US) 1989-02-14 US disclosed
EP-0302373-A1 Process for the preparation of humidity-curing binder compositions, and their use BAYER AG (DE) 1989-02-08 EP disclosed
US-4517379-A ARTIFICIAL SWEETENER PFIZER INC. (US) 1985-05-14 US disclosed
EP-0069811-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-10-24 EP disclosed
EP-0034876-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-08-29 EP disclosed
US-4454328-A SWEETENERS PFIZER INC. (US) 1984-06-12 US disclosed
US-4411925-A STABLE SWEETENERS PFIZER INC. (US) 1983-10-25 US disclosed
US-4399163-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1983-08-16 US disclosed
EP-0069811-A1 Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof PFIZER INC. (US) 1983-01-19 EP disclosed